L-DAB HBR (L-Dab Hydrobromide, L-2,4-Diaminobutyric acid hydrobromide) is an inhibitor of GABA (Gamma-aminobutyric acid) transaminase with IC50 of >500 μM. L-DAB HBR exhibits antitumor activity.
[1] P M Beart, K Bilal. Neurosci Lett. 1977 Jul;5(3-4):193-8. [2] G Ronquist, et al. J Cancer Res Clin Oncol. 1980;96(3):259-68.
















